REVOLAX is a hyaluronic acid (HA) dermal filler, which was developed in South Korea in 2013. It obtained its KFDA approval in the same year and quickly became a staple in the Korean aesthetic industry after its release. In 2017, REVOLAX came to the UK after being awarded its CE Class III certificate meaning it is certified for the use in Europe.

REVOLAX is known for being a premium product, sold at an affordable price. REVOLAX is thoroughly tested, and undergoes several dialysis procedures to meet ISO standards To maintain the same high quality as its market leading competitors. Fox Group International obtained the sole distribution rights for the UK and Germany and is staying true to its company guidelines: Quality, Affordability and Happiness. By sourcing REVOLAX directly from the manufacturer in South Korea, Fox Group International are able to offer REVOLAX to yourself at the lowest possible price.